3.525
Finanzdaten der Compass Therapeutics Inc-Aktie (CMPX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
-
|
- | - | 0.85 | - |
|
17.25%
21.07
|
17.97 | 12.24 | 15.89 | 12.77 |
Depreciation and Amortization |
28.57%
0.10
|
0.14 | 0.143 | 0.152 | 0.154 |
Operating Income/Loss |
17.25%
-21.07
|
-17.97 | -12.24 | -15.04 | -12.77 |
Income/Loss From Continuing Operations Before Tax |
19.53%
-19.88
|
-16.63 | -10.48 | -13.08 | -10.79 |
Income/Loss From Continuing Operations After Tax |
19.53%
-19.88
|
-16.63 | -10.48 | -13.08 | -10.79 |
|
19.53%
-19.88
|
-16.63 | -10.48 | -13.08 | -10.79 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
0.03%
138.28
|
138.24 | 137.59 | 137.59 | 136.61 |
Basic Earnings Per Share |
16.67%
-0.14
|
-0.12 | -0.08 | -0.10 | -0.08 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):